The P84 monoclonal antibody reacts with Signal-Regulatory Protein α (SIRPα), also known as CD172a. SIRPα is a type I transmembrane glycoprotein expressed on monocytes, macrophages, and dendritic cells. Neurons and other tissues of the central nervous system have also been shown to express SIRPα. Its ligand, CD47 is expressed by a wide variety of cells. SIRPα and CD47 regulate dendritic cell-mediated T cell activation, neutrophil migration, and phagocytosis. SIRPα diffuses laterally on the macrophage membrane and accumulates at a phagocytic synapse to bind CD47 which inhibits phagocytosis by macrophages. Anti-SIRPα antibodies that block the interaction of SIRPα with CD47 have been shown to suppress tumor formation in mice. The P84 antibody has been shown to have neutralizing activity in vivo and in vitro.

產(chǎn)品名稱:InVivoMAb anti-mouse CD172a (SIRPα)

反應(yīng)種屬:mouse

宿主來源:Rat

實(shí)驗(yàn)應(yīng)用:in vivo SIRPα blocking, in vitro SIRPα blocking, Western blot, Immunoprecipitation, Flow cytometry

同種型:IgG1, κ

免疫原:Mouse brain membrane protein

克隆性:Monoclonal

克隆號:P84

產(chǎn)品濃度:Lot specific,typically between 4-11 mg/ml

保存溫度:Undiluted at 4°C in the dark

運(yùn)輸溫度:Ship with adequate amount of blue ice to ensure the product remains at 4°C for the duration of transit

預(yù)期分子量:150 kDa

產(chǎn)品形式:液體

有效期:One year from the date of receipt if stored as recommended

產(chǎn)地:美國

如需購買或咨詢Bioxcell公司的產(chǎn)品，請聯(lián)系Bioxcell*代理商欣博盛生物